Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,501,673

« Back to Dashboard

Summary for Patent: 5,501,673

Title: Injection cartridge
Abstract:An injection cartridge of the dual-chamber type has a bypass connection between its two chambers which is arranged such that the interior wall of the cartridge is modified in a determined area in such a way that the movable wall between the two chambers does not seal completely against the interior wall in said area.
Inventor(s): Hjertman; Birger (Vallingby, SE), Levander; Gustav (Bromma, SE), Ljunquist; Olle (Taby, SE)
Assignee: Pharmacia AB (Stockholm, SE)
Application Number:08/325,209
Patent Claim Types:
see list of patent claims
Patent PDF download available with subscription

No matches for this query

Foreign Priority and PCT Information for Patent: 5,501,673

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9201248Apr 21, 1992
PCT Information
PCT FiledApril 16, 1993PCT Application Number:PCT/SE93/00337
PCT Publication Date:October 28, 1993PCT Publication Number: WO93/20868

International Patent Family for Patent: 5,501,673

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria170406<disabled in preview>
Australia4274093<disabled in preview>
Australia673360<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?